ACOR - Acorda Therapeutics Inc. (ACOR) CEO Ron Cohen on Q2 2021 Results - Earnings Call Transcript

Acorda Therapeutics, Inc. (ACOR) Q2 2021 Earnings Conference Call August 5, 2021 04:30 PM ET Company Participants Tierney Saccavino - Executive Vice President-Corporate Communications Ron Cohen - Chief Executive Officer Conference Call Participants Muzamil Saleem - H.C. Wainwright Presentation Operator Ladies and gentlemen, hello and welcome to the Acorda Therapeutics Second Quarter 2021 Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. I will now hand you over to your host Tierney Saccavino, Executive Vice President of Corporate Communications at Acorda to begin. Tierney, please go ahead when you're ready. Tierney Saccavino Thank you, Maxine and good afternoon, everyone. Before we begin, let me remind you that our presentation will contain forward-looking statements. Detailed disclosures can be found in our SEC filings, which are public and we encourage you to refer to those filings. As a reminder to all callers,

For further details see:

Acorda Therapeutics, Inc. (ACOR) CEO Ron Cohen on Q2 2021 Results - Earnings Call Transcript